Related Experiment Videos

Acidic isoferritins do not suppress differentiation of mouse myeloid leukemic M1 cells

Leukemia Research
|January 1, 1983
PubMed

Insights

Resistant mouse myeloid leukemia (M1) cells release factors that inhibit differentiation in both M1 cells and normal bone marrow cells. These factors are distinct from acidic isoferritins, suggesting novel regulatory mechanisms in myeloid leukemia.

Area of Science:

  • Hematology
  • Cell Biology
  • Cancer Research

Background:

  • Mouse myeloid leukemia (M1) cell differentiation into macrophages or granulocytes is a known process.
  • Resistant M1 cell variants that do not differentiate were successfully isolated.

Purpose of the Study:

  • To investigate the regulatory mechanisms of M1 cell differentiation.
  • To identify factors released by resistant M1 cells that inhibit differentiation.

Main Methods:

  • Isolation of M1 cell variants resistant to differentiation induction.
  • Preparation and testing of conditioned medium from resistant M1 cells (RCM).
  • Assays for M1 cell differentiation and normal mouse bone marrow cell colony formation (CFU-GM).
  • Treatment of RCM with anti-acidic isoferritin serum.

Main Results:

  • RCM inhibited M1 cell differentiation and normal bone marrow colony formation.
  • Acidic isoferritins did not inhibit M1 cell differentiation or growth.
  • Anti-acidic isoferritin serum partially neutralized inhibitory activities in RCM, but most activity remained.

Conclusions:

  • M1 cell growth and differentiation are not regulated by acidic isoferritins.
  • M1 cells release additional inhibitory factors affecting normal bone marrow colony formation beyond acidic isoferritins.

Related Concept Videos